Polymerase chain reaction with internal amplification control to detect mycoplasmas in cell cultures and raw materials
Main Article Content
Abstract
The presence of polymerase chain reaction (PCR) inhibitory substances in cell cultures and raw materials used in the manufacture of monoclonal antibodies could limit the usefulness of this method to detect mycoplasma contamination. The objective of this research was to determine the sensitivity and specificity of a PCR method to detect mycoplasma deoxyribonucleic acid (DNA) in MDCK and HeLa cell lines, hybridoma cells, ascitic fluid and cell supernatant containing monoclonal antibodies. The effect of a thermal shock-based mycoplasma DNA extraction method on PCR sensitivity, as well as the performance of two mycoplasma DNA purification methods: silica/guanidinium thiocyanate and a commercial DNA purification kit, were evaluated. In addition, an internal amplification control (IAC) was optimized to detect inhibitory samples from these matrices after thermal shock treatment. PCR-IAC was specific for the amplification of mycoplasma DNA. The inclusion of IAC plasmid at the concentration selected did not decrease the sensitivity of PCR in mycoplasma-spiked matrices. Seventy-eight samples were analyzed; all represented the matrices under study. As a result, all matrices showed PCR inhibition after thermal shock. The inhibitory effect decreased when silica/guanidinium thiocyanate or commercial DNA purification kit was used. PCR-IAC detected 65 % of inhibitory samples and revealed differential susceptibility to inhibitors among different samples of the same matrix.
Article Details
References
European Pharmacopoeia 8.0, 2014; section 2.6.7: Mycoplasmas.
Japanese Pharmacopoeia XIV. Mycoplasma testing for cell substrates used for the production of biotechnological/biological products. 9:1316-1319.
United States Pharmacopoeia, 2010. General Chapter 63. Mycoplasma TestsUSP 33-NF 28.
Center for Biologics Evaluation and Research, Food and Drug Administration. Points to Consider in Characterization of Cell Lines to Produce Biologicals.1993.
Center for Biologics Evaluation and Research, Food and Drug Administration.Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use.1997.
Armstrong S E, J A Mariano and D J Lundin: The scope of mycoplasma contamination within the biopharmaceutical industry. Biologicals. 2010;38(2):211-213.
Russell BJ, Horiuchi K, Velez JO, Goodman CH, Johnson BW. Mycoplasma detection in a historical arbovirus repository: Commercial kit comparison and implications for improved repository management. J Virol Methods. 2020. doi: 10.1016/j.jviromet.2019.113769. Epub 2019
Faison T, Wang J, Johnson S, Brown M, Chiang MJ, Dolan S, et al. Bioprocess: Robustness with Respect to Mycoplasma Species. PDA J Pharm Sci Technol. 2020;74(2):201-212. doi: 10.5731/pdajpst.2018.009613. Epub 2019 Sep 13. PMID: 31519782.
Nikfarjam L, Farzaneh P. Prevention and detection of mycoplasma contamination in cell culture. Cell Journal (Yakhteh). 2012;13(4):203-212.
Uphoff CC, DrexlerHG.Comparative PCR analysis for detection of mycoplasma infections in continuous cell lines. In vitroCell Dev Biol Anim. 2002b;38(2):79-85.
Zhi Y, Mayhew A, Seng N, Takle GB: Validation of a PCR method for the detection of mycoplasmas according to European Pharmacopoeia section 2.6.7. Biologicals. 2010;38:232-237.
Hedman J, Rådström P. Overcoming Inhibition in Real-Time Diagnostic PCR. Methods in Molecular Biology. 2013;943.
Bath C, Scott M, Sharma PM, Gurung RB, Phuentshok Y, Pefanis S, et al. Further development of a reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the detection of foot-and-mouth disease virus and validation in the field with use of an internal positive control. Transbound Emerg Dis. 2020Nov;67(6):2494-2506. doi: 10.1111/tbed.13589. Epub 2020 May 6. PMID: 32311239.
Bessetti J. An Introduction to PCR Inhibitors. Profiles in DNA, 2007.www.promega.com
Timenetsky J, Santos L M, Buzinhani M, Mettifogo E: Detection of multiple mycoplasma infection in cell cultures by PCR. Braz J Med Biol Res. 2006;39(7):907-914.
Harada K, Uchiyama M, Hoshi T, Takahashi T. Comparison of three DNA extraction methods for detection of Erysipelothrix rhusiopathiae in chicken blood by polymerase chain reaction. J Vet Diagn Invest. 2009;21:354-358.
Hoorfar J, Abdulmawjood A, Cook N, Wagner M, Fach P. Practical Considerations in Design of Internal Amplification Controls for Diagnostic PCR Assays. Journal of Clinical Microbiology 2004;42(5):1863-1868.
OIE Terrestrial Manual, 2019. Chapter 1.1.5. Principios y métodos de validación de las pruebas de diagnóstico de las enfermedades infecciosas.
Hayflick L. Tissue cultures and mycoplasmas. Tex Rep Biol Med 1965; 23: 285-303
Fernández C, Chavez I: Use of a Polimerase chain reaction for mycoplasmas detection in cell cultures. Rev Salud Anim. 1999;18(1):31-34.
Van Kuppeveld FJ, Johansson KE, Galama JM, Kissing J, Bolske G, van der Logt JT, et al. Detection of mycoplasma contamination in cell cultures by a mycoplasma group-specific PCR. Appl Environ Microbiol. 1994;60:149-152.
Pérez-Castillo A, Duque-OrtízA,Burgher-Pulgarón Y, Agüero F,Solis MS, Lobo-Rivero E. Development of species-specific PCRs for the detection of mycoplasmas cell culture contaminants. Revista de Salud Animal. 2020;42(2). E-ISSN: 2224-4700.
Lantz PG, Abu Al-Soud W, Knutsson R, Hahn-Hägerdal B, Rådström P. Biotechnical use of the polymerase chain reaction for microbiological analysis of biological samples. Biotechnol Annu ver. 2000;5:87-130.
Abu Al-Soud W, Jönsson L, Radström P. Identification and characterization of inmunoglobulin G in blood as a major inhibitor of diagnostic PCR. J Clin Microbiol. 2000;38:345-350.
Minerva Biolabs. Validation of the Mycoplasma-PCR-Detection Kit VenorGeM®. 2001.
Shutler GG, Gagnon P, Verret G, Kalyn H, Korkosh S, Johnston E, et al. Removal of a PCR inhibitor and resolution of DNA STR types in mixed human canine stains from a five year old case. J Forensic Sci. 1999;44(3):623-626.
OIE Terrestrial Manual, 2019. Chapter 1.1.5. Validation and quality control of polymerase chain reaction methods used for the diagnosis of infectious diseases.
Moalic PY, Gesbert F, Kempf I. Utility of an internal control for evaluation of a Mycoplasma meleagridis PCR test. Vet Microbiol. 1998;61:41-49.
Majidzadeh K, Mohseni A, Soleimani M. Construction and Evaluation of a Novel Internal Positive Control (IPC) for Detection of Coxiella burnetiiby PCR. Jundishapur J Microbiol. 2014;7(1):8849.
Ballagi-Pordany A, Belak S. The use of mimics as internal standards to avoid false negatives in diagnostic PCR. Mol Cell Probes. 1996;10(3):159-64.